Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

TXMD
TherapeuticsMD, Inc.
stock NASDAQ

At Close
Jul 24, 2026
2.06USD0.000%(0.00)31,106
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-2.06)0
After-hours
Jul 24, 2026 4:00:30 PM EDT
2.06USD+0.488%(+0.01)1,016
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
02:41PM EST  Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide   Benzinga
12:17PM EST  Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge   Benzinga
Dec 10, 2021
04:32PM EST  UPDATE: TherapeuticsMD Says 'FDA provided recommendations and requested additional information to address the issues'   Benzinga
04:32PM EST  TherapeuticsMD Reports FDA 'determined that it could not approve proposed revisions to the manufacturing testing limits requested through the Supplemental New Drug Application'   Benzinga
04:31PM EST  TherapeuticsMD Says 'FDA provided recommendations and requested additional information to address the issues'   Benzinga
04:30PM EST  U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA(r)   Business Wire
Dec 8, 2021
09:06AM EST  TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva   Benzinga
08:19AM EST  The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom   Benzinga
06:55AM EST  TherapeuticsMD Settles U.S. Patent Litigation With Amneal For BIJUVA   RTTNews
06:55AM EST  UPDATE: As Part Of Settlement, TherapeuticsMD Granted To Amneal A License To Commercialize Amneal's Generic Version Of BIJUVA In US, Commencing May 25, 2032   Benzinga
06:54AM EST  TherapeuticsMD Settles US Patent Litigation With Amneal For BIJUVA Allowing For A May 25, 2032 Generic Entry Date   Benzinga
06:50AM EST  TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA(r) (Estradiol and Progesterone) - Allowing for a May 25, 2032 Generic Entry Date   Business Wire
Nov 17, 2021
05:20AM EST  TherapeuticsMD Received FDA Approval on Tuesday for Labeling for Imvexxy Under NDA 208564   Benzinga
Nov 12, 2021
06:05AM EST  HC Wainwright & Co. Maintains Buy on TherapeuticsMD, Lowers Price Target to $3   Benzinga
Nov 11, 2021
08:03AM EST  The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts   Benzinga
08:03AM EST  Recap: TherapeuticsMD Q3 Earnings   Benzinga
07:30AM EST  TherapeuticsMD, Inc. (TXMD), an American healthcare company focused on women's wellbeing, said on Thursday that its co-founder and Chief Executive Officer Robert Finizio will step down. The company appointed its current President Hugh O'Dowd as the new chief executive effective December 31 or before.   RTTNews
06:58AM EST  TherapeuticsMD Q3 Net Loss $47.4 Mln Or $0.11/shr Vs Loss $32.6 Mln Or $0.12/shr Prior Year   RTTNews
06:53AM EST  TherapeuticsMD Q3 EPS $(0.11) Misses $(0.10) Estimate, Sales $24.50M Miss $25.87M Estimate   Benzinga
06:52AM EST  TherapeuticsMD Appoints Hugh O'Dowd CEO And Robert G. Finizio Appointed Vice Chair Of The Board   Benzinga
06:51AM EST  TherapeuticsMD Appoints Hugh O'Dowd As CEO   RTTNews
06:50AM EST  TherapeuticsMD Announces Third Quarter 2021 Financial Results   Business Wire
06:45AM EST  TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O'Dowd, as Chief Executive Officer   Business Wire
03:55AM EST  Earnings Scheduled For November 11, 2021   Benzinga
Nov 10, 2021
11:00AM EST  TherapeuticsMD Earnings Preview   Benzinga
Oct 27, 2021
05:00PM EDT  TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021   Business Wire
Oct 15, 2021
05:33PM EDT  TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer   Business Wire
Sep 22, 2021
07:45AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs   Benzinga
Sep 21, 2021
10:25AM EDT  TherapeuticsMD US Patent & Trademark Office Doc Shows Patent Granted For Co.'s 'Soluble estradiol capsule for vaginal insertion'   Benzinga
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 17, 2021
07:36AM EDT  The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold   Benzinga
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 2, 2021
06:50AM EDT  Therapeutics MD Is Urging Women to 'Take Pause' During Menopause Awareness Month   Business Wire
Aug 23, 2021
06:55AM EDT  TherapeuticsMD Announces Issuance Of A J-Code For ANNOVERA To Be Utilized In Public Health Sector   RTTNews
06:54AM EDT  TherapeuticsMD's ANNOVERA Receives a J Code, Which Will Allow Family Planning Clinics With the Ability to Get Reimbursed for Dispensing Annovera   Benzinga
06:50AM EDT  TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA(r) to Be Utilized in the Public Health Sector   Business Wire
Aug 20, 2021
06:03AM EDT  Pre-market Movers: GOVX, PROG, SONN, MRIN,   RTTNews
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 10, 2021
07:55AM EDT  The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts   Benzinga
Aug 9, 2021
04:30PM EDT  TherapeuticsMD Announces Appointment of Hugh O'Dowd as President   Business Wire
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
10:43AM EDT  TherapeuticsMD Earlier Reported Q2 EPS $(0.11), Inline, Sales $23.00M Beat $22.11M Estimate   Benzinga
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
07:15AM EDT  Recap: TherapeuticsMD Q2 Earnings   Benzinga
06:59AM EDT  TherapeuticsMD Q2 Net Loss $42.7 Mln Or $0.11/shr Vs. Loss $52.0 Mln Or $0.19/shr Prior Year   RTTNews
06:53AM EDT  TherapeuticsMD Q2 EPS $(0.11), Inline, Sales $23.00M Beat $22.11M Estimate   Benzinga
06:51AM EDT  TherapeuticsMD Announces Second Quarter 2021 Financial Results   Business Wire
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 26, 2021
06:50AM EDT  TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021   Business Wire
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
May 25, 2021
07:51AM EDT  TherapeuticsMD Inc. (TXMD) said Tuesday that it submitted a supplemental New Drug Application or "sNDA" for BIJUVA or estradiol and progesterone capsules, 0.5 mg/100 mg, to the U.S. Food and Drug Administration.   RTTNews
06:54AM EDT  TherapeuticsMD Submits SNDA For BIJUVA Capsules, 0.5 Mg/100 Mg, To The FDA   RTTNews
06:51AM EDT  TherapeuticsMD Announces Submission Of Low Dose BIJUVA 0.5 mg/100 mg Supplemental New Drug Application To FDA   Benzinga
May 24, 2021
07:00AM EDT  The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award   Business Wire
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 6, 2021
10:56AM EDT  TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume   Benzinga
07:23AM EDT  TherapeuticsMD Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $19.90M Beat $19.77M Estimate   Benzinga
07:00AM EDT  TherapeuticsMD Announces First Quarter 2021 Financial Results   Business Wire
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 5, 2021
10:06AM EDT  A Preview Of TherapeuticsMD's Earnings   Benzinga
May 3, 2021
07:00AM EDT  TherapeuticsMD Announces Poster Presentation of ANNOVERA(r) Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting   Business Wire
Apr 29, 2021
07:00AM EDT  TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021   Business Wire
Apr 8, 2021
04:12PM EDT  TherapeuticsMD And Theramex Announce The Approval Of Its BIJUVE Capsules Indicated For Hormone Replacement Therapy In The United Kingdom And Under The Trade Name BIJUVA In Belgium   Benzinga
04:05PM EDT  TherapeuticsMD and Theramex Announce the Approval of BIJUVE(r) Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA(r) in Belgium   Business Wire
Mar 2, 2021
08:52AM EST  Recap: TherapeuticsMD Q4 Earnings   Benzinga
08:01AM EST  The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data   Benzinga
07:26AM EST  TherapeuticsMD Q4 EPS $(0.15) Misses $(0.10) Estimate, Sales $22.58M Beat $21.89M Estimate   Benzinga
07:22AM EST  Recap: TherapeuticsMD Q4 Earnings   Benzinga
07:19AM EST  TherapeuticsMD Q4 Loss Per Share $0.15 Vs Loss $0.19 Last Year   RTTNews
07:00AM EST  TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results   Business Wire
03:40AM EST  Earnings Scheduled For March 2, 2021   Benzinga
Mar 1, 2021
10:05AM EST  TherapeuticsMD Earnings Preview   Benzinga
07:00AM EST  TherapeuticsMD Announces Participation in Upcoming Investor Conferences   Business Wire
Feb 27, 2021
09:04PM EST  The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings   Benzinga
Feb 23, 2021
04:05PM EST  TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021   Business Wire
Feb 16, 2021
04:02PM EST  TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock   Business Wire
Feb 11, 2021
09:05AM EST  TherapeuticsMD Announces Pricing Of $110 Mln Public Offering Of Common Stock   RTTNews
09:02AM EST  TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock   Business Wire
Feb 10, 2021
04:05PM EST  TherapeuticsMD Announces Underwritten Public Offering of its Common Stock; No Size Disclosed   Benzinga
04:01PM EST  TherapeuticsMD Announces Underwritten Public Offering of its Common Stock   Business Wire
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Dec 29, 2020
07:00AM EST  TherapeuticsMD Announces Participation in Upcoming Investor Conferences   Business Wire
Dec 15, 2020
08:14AM EST  Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina"   Business Wire
Nov 13, 2020
04:05PM EST  TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock   Business Wire
07:00AM EST  TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference   Business Wire
Nov 10, 2020
09:02AM EST  TherapeuticsMD Announces Pricing Of $30M Public Offering At $1.28/Share   Benzinga
09:02AM EST  TherapeuticsMD Prices Underwritten Public Offering Of About 23.4 Mln Shares For $30 Mln   RTTNews
09:02AM EST  CORRECTION: TherapeuticsMD Offering Priced At $1.28/Share   Benzinga
08:58AM EST  TherapeuticsMD Announces Pricing Of $30M Public Offering At $1.52/Share   Benzinga
08:58AM EST  TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock   Business Wire
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
04:04PM EST  TherapeuticsMD Announces Underwritten Public Offering of its Common Stock; No Terms Disclosed   Benzinga
04:01PM EST  TherapeuticsMD Announces Underwritten Public Offering of its Common Stock   Business Wire
07:28AM EST  TherapeuticsMD: Q3 Earnings Insights   Benzinga
07:02AM EST  TherapeuticsMD Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $19.34M Down From $23.72M YoY   Benzinga
06:59AM EST  TherapeuticsMD Q3 Loss Per Share $0.12 Vs Loss $0.13 Last Year   RTTNews
06:55AM EST  TherapeuticsMD(r) Announces Third Quarter 2020 Financial Results   Business Wire
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 29, 2020
07:00AM EDT  TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020   Business Wire
Oct 26, 2020
04:06PM EDT  POPSUGAR Launches New Women's Health Destination, "Full Disclosure," in Collaboration With TherapeuticsMD   Business Wire
10:01AM EDT  ROCE Insights For TherapeuticsMD   Benzinga
Oct 9, 2020
08:00AM EDT  TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health   Business Wire
Oct 6, 2020
10:04AM EDT  Looking Into TherapeuticsMD's Return On Capital Employed   Benzinga
Oct 2, 2020
10:17AM EDT  Return On Capital Employed Overview: TherapeuticsMD   Benzinga
Sep 25, 2020
09:04AM EDT  TherapeuticsMD Says Is On Track To Meet Or Exceed Q3 Sales Of $15.1M; Says 'Underlying retail and wholesale demand for ANNOVERA is strong and growing' But 'believes industry prescription tracking databases are not accurately tracking ANNOVERA'   Benzinga
09:02AM EDT  TherapeuticsMD Provides Update on Third Quarter Progress   Business Wire
Sep 21, 2020
05:01PM EDT  Knight Therapeutics, TherapeuticsMD Report Health Canada Approval Of BIJUVA Capsules   Benzinga
05:01PM EDT  Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA(r)   Business Wire
Sep 9, 2020
04:08PM EDT  TherapeuticsMD Reports New Patents Expand US Patent Protection For ANNOVERA   Benzinga
04:05PM EDT  TherapeuticsMD Announces Patent Updates for ANNOVERA(r)   Business Wire
Aug 25, 2020
07:33AM EDT  Knight And TherapeuticsMD Announce Health Canada Approval Of IMVEXXY   RTTNews
Aug 14, 2020
10:35AM EDT  Return On Capital Employed Overview: TherapeuticsMD   Benzinga
Aug 7, 2020
12:32PM EDT  Jefferies Downgrades TherapeuticsMD to Underperform, Lowers Price Target to $1.2   Benzinga
Aug 6, 2020
08:12AM EDT  TherapeuticsMD Q2 GAAP EPS $(0.19) Misses $(0.17) Estimate, Sales $10.70M Beat $10.20M Estimate   Benzinga
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:18AM EDT  TherapeuticsMD Q2 Net Loss $52 Mln Vs Net Loss $55.2 Mln Last Year   RTTNews
06:50AM EDT  TherapeuticsMD(r) Announces Second Quarter 2020 Financial Results   Business Wire
Jul 29, 2020
06:50AM EDT  TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020   Business Wire
Jul 15, 2020
06:50AM EDT  TherapeuticsMD And Nurx Expand Access To ANNOVERA   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC